|Home | About | Journals | Submit | Contact Us | Français|
The genetic diseases Hutchinson-Gilford progeria syndrome (HGPS) and restrictive dermopathy (RD) arise from accumulation of farnesylated prelamin A due to defects in the lamin A maturation pathway. Both of these diseases exhibit symptoms which can be viewed as accelerated aging. The mechanism by which accumulation of farnesylated prelamin A leads to these accelerated aging phenotypes is not understood. Here we present evidence that in HGPS and RD fibroblasts, DNA damage checkpoints are persistently activated due to the compromise of genomic integrity. Inactivation of checkpoint kinases Ataxia-Telangiectasia Mutated (ATM) and ATR (ATM and RAD3-Related) in these patient cells can partially overcome their early replication arrest. Treatment of patient cells with a protein farnesyltransferase inhibitor (FTI) did not result in reduction of DNA double strand breaks and damage checkpoint signaling, although the treatment significantly reversed the aberrant shape of their nuclei. This suggests that DNA damage accumulation and aberrant nuclear morphology are independent phenotypes arising from prelamin A accumulation in these progeroid syndromes. Since DNA damage accumulation is an important contributor to the symptoms of HGPS, our results call into question on the possibility of treatment of HGPS with FTIs alone.
Hutchinson-Gilford progeria syndrome (HGPS) is a severe childhood disease characterized by accelerated aging, which is caused by a de novo point mutation (1824C → T) in the LMNA gene, which encodes lamin A and the splice variant lamin C and germ cell-specific lamin C2 (De Sandre-Giovannoli et al., 2003; Eriksson et al., 2003). These lamins are intermediate filament proteins composing the nuclear lamina, a scaffold underlying the inner nuclear membrane that structurally supports the nucleus and organizes chromatin (Goldman et al., 2002). The point mutation (1824C → T) of LMNA results in defective maturation of lamin A from its precursor prelamin A by causing a deletion of 50 amino acids near the C terminus of prelamin A, which contains an endoprotease (Zmpste 24) cleavage site required for the proteolytic maturation of lamin A (Eriksson et al., 2003). Zmpste 24 mutation leads to another progeroid disorder, restrictive dermopathy (RD), which is neonatally lethal (Navarro et al., 2005). Loss of Zmpste 24 activity arrests the processing of prelamin A at a stage similar to HGPS, although a unique truncated prelamin A (progerin) is accumulated in HGPS cells. Based on our prior elucidation of the prelamin A processing pathway (Sinensky et al., 1994b), these mutations are predicted to result in accumulation of farnesylated and carboxymethylated prelamin A. These two diseases have been suggested to be manifestations of the same cellular problem to different degrees (Misteli and Scaffidi, 2005). Although the molecular mechanisms by which theses mutations result in premature aging are far from full understanding, Liu et al. (Liu et al., 2005a) recently reported that human HGPS fibroblasts and Zmpste24-deficient mouse embryonic fibroblasts (MEFs) showed increased DNA damage and repair defects. In addition, Varela et al. (Varela et al., 2005) showed that Zmpste24 deficiency in mouse elicits the upregulation of p53 target genes. These studies suggest that the genomic integrity was compromised in HGPS and RD cells due to the accumulation of progerin and prelamin A, respectively.
Accumulation of DNA damage may activate DNA damage and replication checkpoints, which attenuate cell cycle progression and arrest replication, thereby preventing DNA lesions from being converted to inheritable mutations (Li and Zou, 2005). Two protein kinases of the phosphoinositide 3-kinase-like kinase (PIKK) family, ATM and ATR, play the central roles in initiating the damage and replication checkpoints (Abraham, 2001; Li and Zou, 2005). ATM is activated primarily in response to DNA double-strand breaks (DSBs) (Shiloh, 2003), whereas ATR is activated by a broad range of DNA damage and replication interference (Abraham, 2001; Li and Zou, 2005). Upon activation, ATM and ATR phosphorylate two major signal-transducing kinases Chk1 and Chk2, which in turn regulate downstream targets, such as Cdc25A, Cdc25C, and p53, to control cell cycle progression and DNA synthesis (Li and Zou, 2005; Sancar et al., 2004). It has been reported that in telomere-initiated senescence, a checkpoint response similar to that in the cells with DNA-damage stress was activated involving ATM, ATR, and downstream kinases Chk1 and Chk2 (d'Adda di Fagagna et al., 2003; von Zglinicki et al., 2005). Kinase inactivation experiments showed that this signaling pathway has to be maintained in order to keep cells in a senescent state (d'Adda di Fagagna et al., 2003; von Zglinicki et al., 2005). DNA damage accumulation and responses resulting from repair defects may lead to phenotypes associated with premature aging and may have causal roles in normal aging (Lombard et al., 2005). Furthermore, evidence has been presented that progerin expression occurs during the normal aging process (Scaffidi and Misteli, 2006). Given the similarities between these progeroid syndromes and and normal aging, we speculated that the same signaling pathway of DNA damage response is activated in HGPS and RD cells as in telomere-initiated senescence.
Several recent studies have shown that inhibition of prelamin A farnesylation by protein farnesyltransferase inhibitors reversed the aberrant nuclear morphology of progeroid cells (Capell et al., 2005; Mallampalli et al., 2005; Toth et al., 2005). However, the important question as to whether treatment with farnesyltransferase inhibitors concurrently restores the genomic integrity in these cells remains to be addressed.
In this study, we report that DNA damage checkpoints were constantly activated in HGPS and RD cells due to DNA defects. Strikingly, inactivation of ATR and ATM by specific kinase inhibitor or RNAi partially restored DNA replication in HGPS cells. Also importantly, treatment of the patient cells with a protein farnesyltransferase inhibitor (FTI) was found to have no effect on DNA damage in these cells.
Results from our studies (Fig. 3) and others (Liu et al., 2005a; Varela et al., 2005) showed that a considerable amount of phosphorylated histone H2AX (γ-H2AX), a molecular marker for DNA double-strand breaks (DSBs) (Sedelnikova et al., 2002), formed in HGPS and RD cells. This indicates that DNA damage accumulates in patient cells. To determine the status of DNA replication in these cells, a DNA replication assay with replicative incorporation of [methyl-3H] thymidine was performed. As shown in Fig. 1, DNA synthesis in the HGPS and RD cells of passage 11 occurred at rates more than 2-fold slower than that in BJ cells, a non-transformed human diploid fibroblast cell line. Moreover, replicative capacity was lost at passage 15 for RD cells and at passage 21 for HGPS cells (Fig. 1) in contrast to the more typical replicative behavior of BJ cells which exhibit many more passages before undergoing replicative senescence (Steinert et al., 2000). This premature replicative senescence of the patient cells is consistent with the previous reports that the percentage of S-phase cells in Zmpste24-deficient mouse embryonic fibroblasts (MEFs) was lower than that in normal MEFs (Liu et al., 2005a; Varela et al., 2005).
The premature replicative senescence of HGPS and RD cells suggested that G1/S and/or intra-S checkpoints were likely activated. To test this notion, we assessed the activation of ATM and ATR, two central initiators of DNA damage checkpoints (McGowan and Russell, 2004), in HGPS and RD cells using the method of immunofluorescence microscopy. In BJ cells, the majority of ATM was homogenously distributed in the nucleus (Fig. 2A). The treatment of BJ cells with camptothecin (CPT), a radiomimetic agent widely used to induce DSBs and activate ATM in cells (Shiloh, 2003), caused ATM focus formation in the nuclei (Fig. 2A). Interestingly, a very similar pattern of ATM nuclear focus formation was observed in HGPS and RD cells even without treatment with CPT, suggesting that ATM was activated in these cells (Fig. 2A). By contrast, a different pattern of activation was observed for ATR in these patient cells. In unstressed BJ cells, ATR was mainly localized in cytoplasm, with little or no nuclear staining (Fig. 2B). After UV irradiation, a known DNA damaging stress that induces ATR activation (Abraham, 2001), ATR translocated from cytoplasm into the nucleus. Interestingly, while the majority of ATR was in the nuclei of untreated RD cells, only part of ATR was distributed in the nuclei of HGPS cells and formed large foci or aggregates (Fig. 2B). The nuclear distribution of ATR in RD and HGPS cells suggests its activation in these cells, which is confirmed by the phosphorylation of its primary substrate Chk1 (see below). To verify that nuclear translocation of checkpoint kinases in the patient cells arises from expression of prelamin A, HeLa cells were transfected with a plasmid encoding progerin (LAΔ50) for immunofluorescence analysis. As shown in Fig. 2C, the majority of ATR was in cytoplasm in HeLa cells transfected with an empty parent vector. In contrast, ATR was mainly located in nuclei, forming large foci in the HeLa cells transfected with the LAΔ50-expression plasmid. This indicated that the nuclear translocation of checkpoint kinases was indeed induced by the presence of progerin. Thus, DNA damage in HGPS and RD cells, arising from prelamin A accumulation, results in nuclear distribution of ATR and ATM, consistent with activation of cell cycle checkpoints.
To confirm the presence of checkpoint response pathways in HGPS and RD cells, we next examined the activation of downstream signal-tranducers Chk1 and Chk2, and the effector p53, by assessing their phosphorylation status at specific sites (Helt, 2005). As shown in Fig. 3, besides phosphorylation of H2AX, phosphorylation of Chk1 (Ser-345), Chk2 (Thr-68), and p53 (Ser-15) were all readily detected in HGPS and RD cells, confirming the activation and signaling of checkpoint pathways in these cells.
DNA damage checkpoint responses are complex signaling pathways orchestrated by the PIKK family including ATM and ATR (Abraham, 2001). Cells with deficient ATM and/or ATR are defective in initiating DNA damage-induced cell-cycle arrest (Shiloh, 2003). To test whether inactivation of ATM and ATR could abolish the premature senescence observed in the patient cells, we treated cells with 5 mM caffeine, an ATM and ATR inhibitor (Sarkaria et al., 1999), and measured their DNA synthesis by [methyl-3H] thymidine labeling. As shown in Fig. 4A, both ATM and ATR were efficiently knocked down in BJ and HGPS cells transfected with ATR and ATM siRNAs. The observation of lower cellular levels of ATM and ATR in GFP siRNA-transfected HGPS cells than their levels in corresponding BJ cells could be due to the tight chromatin association of ATM and ATR in the checkpoint-activated HGPS cells. These proteins could be partially resistant to extraction for Western blot analysis. However, regardless of the basis for the lowered levels of ATM and ATR in the controls a relative knockdown by the siRNAs was observed. As shown in Fig. 4B, the knockdown significantly increased DNA synthesis in HGPS cells, while having no obvious effect on that of the control BJ cells. Similar data were produced by treating the cells with caffeine (Fig. 4B). These results confirm that DNA damage checkpoints were activated in the patient cells, and demonstrate that the replicative senescence of these patient cells can be reversed by inactivation of checkpoint kinases.
Recent studies showed that FTI treatment can correct aberrant nuclear morphology in HGPS fibroblasts (Capell et al., 2005; Mallampalli et al., 2005; Toth et al., 2005) and RD fibroblasts (Toth et al., 2005). FTI treatment also ameliorates disease phenotypes in Zmpste24-deficient mice (Fong et al., 2006). Since DNA damage accumulation is believed to be one of the major causes of accelerated aging, cellular senescence and normal aging (d'Adda di Fagagna et al., 2003; Gorbunova and Seluanov, 2005; Kirkwood, 2005; Lees-Miller, 2005; Lombard et al., 2005; Misteli and Scaffidi, 2005; von Zglinicki et al., 2005), it is of great interest to test whether FTIs also can reduce the accumulated DNA damage in these cells. As shown in Fig. 5A, treatment of HGPS and RD fibroblasts of passage 15 with L-744832, a potent FTI (Capell et al., 2005), significantly reduced the percentage of cells with misshapen nuclei (from 47% to 11% for RD cells, P < 0.005; from 33% to 6% for HGPS cells, P < 0.001). The misshapen nuclei were defined as nuclei with blebs, folds, or gross irregularities in shape (Toth et al., 2005), and the counting was carried out by two observers who randomly chose 200 cells from each experiment group. This result confirms that FTI treatment can normalize the nuclear morphology of the patient cells. Consistently, FTI treatment of BJ and HGPS fibroblasts caused accumulation of prelamin A in these cells as analyzed by Western blotting (Fig. 5B) with prelamin A specific antibody (Sinensky et al., 1994a), demonstrating the efficacy of the FTI in blocking farnesylation in cells. By contrast, however, no substantial reduction of DSBs was detected in HGPS and RD cells after FTI treatment, as evidenced by the amount of γ-H2AX analyzed by Western blotting (Fig. 5B). The same HGPS cells were also subjected to single cell gel (SCG) electrophoresis or comet assays which directly measured the DSBs in cells. As shown in Fig. 5C, there was no substantial difference in the amount of DNA damage generated in the cells with and without FTI treatments. In addition, ATM and ATR damage checkpoint signaling was also examined. As shown in Fig. 5D, both the checkpoint substrates, Chk1 and Chk2, of ATR and ATM, were well phosphorylated in FTI treated and untreated HGPS cells, indicating their activation. Importantly, the phosphorylation was equally efficient in the cells with or without FTI treatment. These observations indicated that FTI treatment was unable to reduce the accumulated DNA damage in these cells despite its capacity to improve the nuclear morphology.
To further confirm the results, pEGFP-LAΔ50 and pEGFP-LAΔ50-SIIM plasmid constructs, respectively, were transfected into HeLa cells. pEGFP-LAΔ50-SIIM is a construct for expression of the LAΔ50 with a mutation at its farnesylation site, making the progerin prenylation-incompetent (Capell et al., 2005). Unlike FTI treatment which may not be able to completely abolish the farnesylation of progerin, expression of pEGFP-LAΔ50-SIIM produces only the unfarnesylated LAΔ50. As shown in Fig. 5E, the expression of LAΔ50 and prenylation incompetent LAΔ50-SSIM in HeLa cells induced similar levels of γ-H2AX accumulation, indicating that farnesylation had no substantial effect on the cellular DNA damage accumulation induced by progerin. This is consistent with the above results obtained with HGPS cells. Our results also suggested that DNA damage accumulation and misshapen nuclei are perhaps two independent phenotypes produced by prelamin A accumulation in HGPS and RD.
DNA damage is believed to contribute to both aging and cellular senescence (Lombard et al., 2005) which has been regarded as a permanently maintained DNA damage response state (von Zglinicki et al., 2005). Defects in several DNA repair proteins lead to DNA damage accumulation and damage responses, which cause phenotypes reminiscent of premature ageing (Lombard et al., 2005). As there is no evidence for any mutations in DNA repair genes in HGPS and RD cells, we, and others, hypothesize that prelamin A accumulation affects DNA repair in these syndromes. In this study, we present direct evidence that DNA damage checkpoints were constantly activated in HGPS and RD cells due to accumulated DNA damage. We also demonstrated that the subcellular distribution of checkpoint kinases ATM and ATR may be used as an indicator for their activation in vivo. Inactive ATM is homogenously distributed in the nucleus, while nuclear focus formation of ATM indicates its activation. In unstressed cells, ATR is mainly localized in cytosol, but translocates into the nucleus upon DNA damaging stress such as UV irradiation. Our finding is contradictory to that of Manju et al. (Manju et al., 2006) who recently reported that ATR was normally localized in the nucleus. The explanation for this discrepancy may lie in the fact that FLAG-ATR was ectopically expressed in cells in the Manju et al. study, while we used normal cells and stained endogenous ATR directly. The expression of exogenous proteins likely induces stress to the cells, which may cause the translocation of ATR from cytosol to the nucleus. In the present study, activation of ATR and ATM in the patient cells as evidenced by immunofluorescence determination was confirmed by the phosphorylation of their downstream substrates Chk1, Chk2, and p53 as analyzed by Western blotting.
Interestingly, inactivation of ATM and ATR in HGPS cells partially restored cell-cycle progression into S phase. This confirms that a form of prelamin A (progerin) activated DNA damage responses, leading to replicative senescence. Importantly, this senescence can be suppressed by inactivating DNA damage response pathways in HGPS cells. That only partial restoration of S-phase progression is observed is likely due to the incomplete repression of the DNA damage responses as even a residual kinase activity could be sufficient to enforce a DNA damage checkpoint (Cortez et al., 2001). Varela et al. showed that p53 knockout completely recovered the proliferative capacity of Zmpste24−/− mouse cells (Varela et al., 2005). We expect that a highly efficient checkpoint inhibition would permit a significant recovery of cell division and alleviate many other senescence-associated phenotypes in progeroid cells.
Aberrant nuclear morphology is the most obvious phenotype caused by prelamin A accumulation in HGPS and RD fibroblasts (Goldman et al., 2004; Toth et al., 2005). Recent studies showed that FTI treatment could correct the nuclear morphology defects of progeroid cells (Capell et al., 2005; Glynn and Glover, 2005; Mallampalli et al., 2005; Toth et al., 2005). However, we found that FTI treatment could not reduce the accumulated DSBs in both HGPS and RD cells. This suggests that DNA damage accumulation and misshapen nuclei are probably two unrelated phenotypes caused by prelamin A accumulation in HGPS and RD. Consistent with this notion, p53 knockout can restore proliferative capacity of Zmpste24−/− mouse cells, but only partially reverse other disease phenotypes (Varela et al., 2005), suggesting that independent pathological pathways exist and cooperate with each other in the generation of progeroid phenotypes. Thus, strategies for treatment of HGPS need to combine elimination of DNA damage accumulation as well as normalization of nuclear morphology.
Fibroblasts from a HGPS patient with the point mutation 1824 C → T were obtained from the Coriell Cell Repository (no. AG11513A). Human RD fibroblasts were a gift from Dr. J.H. Miner (Washington University School of Medicine, St Louis, MO). BJ cells and HeLa cells were purchased from American Type Culture Collection (ATCC, nos. CRL-2522 and CCL-2, respectively). All cultures were maintained in DMEM (for RD cells and HeLa cells) or EMEM (for HGPS cells and BJ cells) supplemented with 10% FBS and antibiotics (50 units/ml penicillin and 50 μg/ml streptomycin) at 37°C under an atmosphere containing 5% CO2. For FTI treatment, cells were cultured to 70% confluence, and treated with 5 μM FTI L-744832 (Biomol, Plymouth Meeting, PA) daily for 72 hours before harvest. For the inactivation of ATR and ATM, cells were treated with caffeine at a final concentration of 5 mM for at least 2 hour before further analysis.
Cells were grown on coverslips to 70% confluence, washed twice with PBS, and then fixed with cold methanol (−20°C) or with 1% formaldehyde followed by permeabilization with 0.5% Triton X-100. The fixed cells were blocked with 15% FBS, and then incubated with a primary antibody against ATR (rabbit or mouse, GeneTex), ATM (mouse, GeneTex), GFP (rabbit, ABCAM), or γ-H2AX (mouse, Stressgen). After three washes with PBS/1% Tween 20, the cells were incubated with a secondary antibody Alexa fluor 488-conjugated donkey anti-rabbit IgG or Alexa fluor 568-conjugated goat anti-mouse IgG (Molecular Probes). Nuclei were counterstained with DAPI. Cells were visualized by using a Zeiss Axioscope microscope.
HeLa cells grown on coverslips were transiently transfected with plasmid pEGFP-LAΔ50, pEGFP-LAΔ50-SSIM (both were gifts from Dr. Francis Collins, NIH), control plasmid pEGFP, or empty parent vector using GeneJammer transfection reagent (Stratagene) following manufacture's instruction. 24-hour post-transfection, the cells were processed differently for the following experiments. For examining the activation of ATM and ATR, the cells were irradiated with 20 J/m2 UV or mock treated. 2-hour post-treatment, the cells were processed for immunofluorescence microscopy as described above. To measure the amount of γ-H2AX, the cells were harvested and lysed for Western blotting as described below. For detecting the formation of γ-H2AX foci, the cells were fixed with 1% formaldehyde and processed for immunofluorescence.
For the knockdown of ATR and ATM by RNAi, the cells were transfected with ATR siRNA and ATM siRNA (Wu et al., 2006), or GFP siRNA as a control using TransIT-TKO transfection reagent (Mirus) following manufacture's instruction. Further analyses were performed 72 hours after transfection.
DNA synthesis was assayed by the method of thymidine incorporation modified from Shao et al. (Shao et al., 1997). Briefly, 2 × 105 cells were seeded in a 35-mm dish 24 hours before pulse-labeling with 0.5 μCi/ml [methyl-3H]thymidine (Amersham Biosciences) for 30 minutes. The cells were then rinsed with PBS three times and harvested by lysis with 5% trichloroacetic acid (TCA) at 4 °C for 1 hour. Cell lysates were subjected to filtering using Whatman glass microfibre filters and a vacuum manifold. The filters were washed twice with 5 ml of 5% TCA, once with 70% ethanol, and then dried. The radioactivity of each sample was counted by liquid scintillation.
Cells cultured in 100-mm dishes were grown to 70% confluence, and then trypsinized. Cell number was counted by using a hemacytometer. The cells were centrifuged at 1500 rpm for 5 minutes and washed twice with PBS. Cell pellet was lysed in 2 × SDS gel loading buffer and volumes corresponding to 5 × 106 cells were subjected to SDS-PAGE. Immunoblotting was carried out as previously described (Liu et al., 2005b) with primary antibodies directed against p53 (Santa Cruz), p53 (ser-15) (Cell Signaling), Chk2 (thr-68) (Cell Signaling), Chk1 (ser-345) (Santa Cruz), γ-H2AX (Bethyl), GAPDH (Santa Cruz), LaminA/C (Santa Cruz), and β-actin (Santa Cruz). The rabbit anti-mouse prelamin A antiserum used was generated specifically against the carboxyl-terminal prelamin A and cannot bind mature lamin A or lamin C (Sinensky et al., 1994a).
The neutral comet assay was performed to assess DNA strand breaks in cells. The first layer of agarose on microscope slides were prepared by dipping the slides into 1% NMA followed by drying. 85 μl of 0.5% LMA containing 4 × 105 cells was made by mixing 10 μl cell suspension with 75 μl LMA, and then poured onto the pre-coated slides. Slides were immersed in freshly prepared ice-cold buffer (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris–HCl, 1% Triton X-100, pH 10) to lyse the cells for at least 1 hr at 4 °C in the dark. The slides were then placed in the alkaline buffer (0.3 M NaOH, 1 mM EDTA, pH > 13) for 30 minutes for DNA unwinding. The slides were equilibrated in TBE buffer for 5 minutes twice followed by electrophoresis at 1 volt/cm in TBE buffer for 10 minutes. The slides were then dipped in 70% ethanol for 5 minutes and dried at room temperature for 1 hr. 50 μl of 600 μM DAPI was used for staining. All steps described above were conducted under dimmed light to prevent additional DNA damage. The quantification of the comets was conducted for randomly chosen 50 cells, and DNA damage was expressed as the percentage of DNA in tail.
This study was supported by NCI grant CA86927 (to Y.Z.)